Zinc Patents (Class 424/641)
  • Publication number: 20140220155
    Abstract: A method of stimulating elastin and/or collagen production in the tissues of the vagina, comprising the steps of providing a composition including at least one of a water soluble zinc salt such as zinc sulfate and a peroxisome proliferator-activated receptor beta/delta (PPAR 13/8) agonist, and administering the composition to the tissue of the vagina. Compositions for stimulating 5 elastin and/or collagen production in the tissues of the vagina are also disclosed.
    Type: Application
    Filed: July 10, 2012
    Publication date: August 7, 2014
    Applicant: UNIVERSITY OF MIAMI
    Inventors: Peter Takacs, Keith A. Candiotti, Carlos A. Medina
  • Publication number: 20140220157
    Abstract: The present invention relates to ionic compositions for debriding a tissue, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride.
    Type: Application
    Filed: April 9, 2014
    Publication date: August 7, 2014
    Applicant: RED OAX HOLDINGS, LLC
    Inventor: Kevin Powers
  • Publication number: 20140220145
    Abstract: An improved method for stimulating electrical activity in an eye is provided. Provided is a technique for implanting small, nanometer-sized photoactive devices into an eye to improve electrical activity within an eye or mitigate degradation of electrical response in damaged eyes.
    Type: Application
    Filed: April 9, 2014
    Publication date: August 7, 2014
    Applicant: The Regents of the University of Colorado, a Body Corporate
    Inventors: Jeffrey Olson, Naresh Mandava
  • Publication number: 20140220156
    Abstract: The present invention relates to ionic compositions for promoting mucosal reciliation, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride.
    Type: Application
    Filed: April 9, 2014
    Publication date: August 7, 2014
    Applicant: Red Oax Holdings, LLC
    Inventor: Kevin Powers
  • Patent number: 8796476
    Abstract: Pest controlling compositions exhibiting enhanced pesticidal activity levels and methods for preparing the same are disclosed. In one embodiment, a method includes providing a liquid composition that includes at least one pesticide and at least one co-ingredient that enhances pesticidal activity of the composition compared to a composition dissimilar only in not having the at least one co-ingredient. The at least one co-ingredient may include at least one metal oxide, a combination of at least one transition metal salt and at least one proteinaceous material or a combination of at least one proteinaceous material and at least one polymeric material. The method further includes spray drying the liquid composition to provide a solid composition. In one aspect of this embodiment, the solid composition provided by the spray drying exhibits enhanced pesticidal activity compared to the liquid composition.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: August 5, 2014
    Assignee: Dow AgroSciences, LLC
    Inventors: Stephen L. Wilson, Lei Liu, James D. Thomas, Raymond E. Boucher, Jr., James E. Dripps, Margaret S. Kempe, Martin C. Logan, Douglas J. Linscott, John M. Atkinson
  • Publication number: 20140212507
    Abstract: Disclosed is a method for determining a supplement regime for a subject diagnosed with age-related macular degeneration (AMD). The method involves determining the subject's risk of developing advanced AMD based on their genetic profile for the complement factor H gene and the ARMS2 gene and administering a supplement containing antioxidants and/or zinc based on their risk of developing advanced AMD.
    Type: Application
    Filed: July 31, 2013
    Publication date: July 31, 2014
    Applicant: ArcticDx Inc.
    Inventors: Brent Zanke, Carl Awh
  • Patent number: 8790712
    Abstract: The present invention is drawn to a method of inducing thymocyte proliferation in a vertebrate animal with an impaired immune system comprising administering ?-aminolevulinic acid or a salt thereof every day in succession. The method further comprises administering at least one mineral.
    Type: Grant
    Filed: August 26, 2005
    Date of Patent: July 29, 2014
    Assignees: Cosmo Oil Co., Ltd., SBI Pharmaceuticals Co., Ltd.
    Inventors: Masao Kondo, Naomi Aiba, Setsuko Miyanari, Tohru Tanaka, Takaya Suzuki, Masahiro Ishizuka
  • Publication number: 20140205642
    Abstract: A method of preparing antimicrobial-containing polymeric products is provided, the method involving electrospinning a dispersion comprising a dispersible polymer, a fiberizing polymer, and one or more antimicrobial agents. The electrospun material is heated to remove solvent and the fiberizing polymer, giving a nonwoven polymeric material having antimicrobial agent incorporated therein. The material can be in the form of, for example, a non-woven sheet, tube, or covering.
    Type: Application
    Filed: February 7, 2014
    Publication date: July 24, 2014
    Applicant: Zeus Industrial Products, Inc.
    Inventors: Robert L. Ballard, Bruce L. Anneaux, Joshua L. Manasco
  • Patent number: 8785194
    Abstract: The present invention provides a cell culture medium formulation that supports the in vitro cultivation, particularly in suspension, of mammalian cells, particularly epithelial cells and fibroblast cells, and methods for cultivating mammalian cells in suspension in vitro using these media. The media comprise a basal medium and a polyanionic or polyanionic compound, preferably a polysulfonated or polysulfated compound, and more preferably dextran sulfate. The present invention also provides chemically defined, protein-free eukaryotic cell culture media comprising an iron chelate and zinc, which is capable of supporting the growth (and particularly the high-density growth of mammalian cells) in suspension culture, increasing the level of expression of recombinant protein in cultured cells, and/or increasing virus production in cultured cells.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: July 22, 2014
    Assignee: Life Technologies Corporation
    Inventors: Stephen Gorfien, Richard Fike, Glenn Godwin, Joyce Dzimian, David A. Epstein, Dale Gruber, Don McClure, Paul Price
  • Publication number: 20140200138
    Abstract: The present invention provides a composition comprising an acidified aqueous solution of (1) micro colloidal silicic acid, (2) boric acid, and (3) a water absorbing additive, having a pH value of equal to or less than 1, wherein the micro colloidal silicic acid has particle sizes in the range of 1-8 nm, especially in the range of 1.5-6 nm. The invention also provides a particulate product obtainable by the method according to claim 18, wherein the particles comprise (1) silicic acid, (2) boric acid, and (3) the water absorbing additive, and wherein at least 90% of the particles in the particulate product have particle sizes in the range of 0.3-5 ?m.
    Type: Application
    Filed: December 13, 2013
    Publication date: July 17, 2014
    Applicant: Barlaa B.V.
    Inventors: Henk Maarten LAANE, Walter Ferdinand WITTERLAND
  • Patent number: 8778410
    Abstract: The present invention provides an oral or enteral composition incorporating not only BCAA but other nutrients to be conducive to comprehensive recovery from fatigue, and improvement in total physical condition. The oral or enteral composition is formulated as a composite of a branched-chain amino acid, coenzyme Q10, L-carnitine, a citric acid, and zinc.
    Type: Grant
    Filed: February 19, 2009
    Date of Patent: July 15, 2014
    Assignees: Earnest Medicine Co., Ltd., Otsuka Pharmaceutical Factory, Inc.
    Inventors: Takashi Higashiguchi, Takako Hatakeyama
  • Patent number: 8778409
    Abstract: A composition, system and method for modifying an olfactory response to an odorant is disclosed. In some embodiments, the composition includes crystalline metal nanoparticles dispersed in an aqueous medium. The composition is applied to olfactory tissues using a suitable applicator or dispenser. The metal nanoparticles are believed to interact with a G-protein coupled to receptor located in the cilia to moderate (enhance or reduce) sensitivity or ability to smell particular odorants. In accordance with an embodiment of the invention, the composition includes one or more odorants.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: July 15, 2014
    Assignee: Auburn University
    Inventors: Vitaly J. Vodyanoy, Lewis G. Scharpf, Alexandre Samoylov, Nilmini Viswaprakash, Ludmila Petrovna Globa, Edward E. Morrison
  • Patent number: 8772334
    Abstract: A broad spectrum antimicrobial composition consisting essentially of an iodopropynyl compound in combination with a benzimidazole and a metal borate is disclosed. The composition can be used to protect industrial systems against microbial growth and, more particularly, to protect substrates such as paints, coatings, stucco, concrete, stone, cementaceous surfaces, wood, wood-plastic composites, caulking, sealants, textiles, leather, wood, preservatives, metal working fluids, drilling muds, clay slurries, glazes, optical brighteners, carpet backing, and pigments against microbial growth. The composition can be used as a preservative for aqueous products.
    Type: Grant
    Filed: July 18, 2011
    Date of Patent: July 8, 2014
    Inventors: Kamlesh Gaglani, Maihua Yang
  • Patent number: 8765163
    Abstract: The present invention relates to a biocompatible ceramic material comprising Sr, Mg or Ba doped Hardystonite (Ca2ZnSi2O7), and a method for its synthetic preparation. The present invention also relates to an implantable medical device comprising biocompatible doped Hardystonite, and a method for its production. The present invention further relates to a method for improving the long term stability of an implantable medical device and an implantable drug delivery device comprising doped Hardystonite. Further, the present invention relates to the use of comprising biocompatible doped Hardystonite in the regeneration or resurfacing of tissue.
    Type: Grant
    Filed: July 10, 2009
    Date of Patent: July 1, 2014
    Assignee: The University of Sydney
    Inventors: Hala Zreiqat, Chengtie Wu, Colin Dunstan
  • Patent number: 8758835
    Abstract: It is described a composition comprising as active ingredients green tea extract and pomegranate extract for the prevention or reduction of the progression of prostate cancer.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: June 24, 2014
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Franco Gaetani, Ashraf Virmani
  • Patent number: 8753561
    Abstract: Methods for processing substrate surfaces comprising metallic nanoparticles are disclosed. The methods involve providing a substrate surface comprising metallic nanoparticles, and exposing the substrate surface to a plasma.
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: June 17, 2014
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Yann-Per Lee, John-Bruce D. Green, Jeffrey Bloss, Ozlem Yardimci
  • Publication number: 20140161906
    Abstract: The present application describes therapy with angiogenesis antagonists such as anti-VEGF antibodies. In particular, the application describes the use of such angiogenesis antagonists to treat end-stage liver disease and end-stage liver disease complications. The present application also describes the use of such angiogenesis antagonists to treat disorders of altered venous proliferation such hemorrhoids and varicose veins.
    Type: Application
    Filed: June 12, 2013
    Publication date: June 12, 2014
    Applicant: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Jason Schwartz, Thomas P. Kennedy
  • Publication number: 20140161851
    Abstract: Cosmetic or dermatological compositions and substrates, containing a NIR light-emitting material, and methods for stimulating healing and/or regenerative properties in the skin, hair and/or scalp are provided.
    Type: Application
    Filed: December 3, 2013
    Publication date: June 12, 2014
    Applicant: ELC Management LLC
    Inventor: William Robert Bickford
  • Publication number: 20140161850
    Abstract: Cosmetic or dermatological compositions and substrates, containing a NIR light-emitting material, and methods for stimulating healing and/or regenerative properties in the skin, hair and/or scalp are provided.
    Type: Application
    Filed: December 3, 2013
    Publication date: June 12, 2014
    Applicant: ELC Management LLC
    Inventor: William Robert Bickford
  • Publication number: 20140161907
    Abstract: The present invention relates to compositions that may be swallowable, chewable or dissolvable, comprising various vitamins and minerals, and in a specific embodiment comprising vitamin A, beta carotene, B-complex vitamins, vitamin C, vitamin D3, vitamin E, iron, magnesium and zinc, and methods for using these compositions for nutritional supplementation in subjects undergoing physiologically stressful events, such as, for example and without limitation, pregnancy, lactation or any disease state.
    Type: Application
    Filed: February 18, 2014
    Publication date: June 12, 2014
    Inventors: John A. Giordano, Charles J. Balzer
  • Publication number: 20140161849
    Abstract: Cosmetic or dermatological compositions and substrates, containing a NIR light-emitting material, and methods for stimulating healing and/or regenerative properties in the skin, hair and/or scalp are provided.
    Type: Application
    Filed: December 3, 2013
    Publication date: June 12, 2014
    Applicant: ELC Management LLC
    Inventor: William Robert Bickford
  • Publication number: 20140154292
    Abstract: Articles have a glass layer on a substrate. The glass layer has antimicrobial properties via a metal or metal alloy. The glass layer is made using a doped glass frit which may be deposited by screen printing. The CTE of the glass layer and the substrate can be matched.
    Type: Application
    Filed: November 21, 2013
    Publication date: June 5, 2014
    Applicant: CORNING INCORPORATED
    Inventors: Nicholas Francis Borrelli, Melinda Ann Drake, Robert Michael Morena
  • Publication number: 20140154337
    Abstract: Antimicrobial agents and methods for the abatement of food borne pathogenic organisms—particularly, Escherichia coli—include the steps of providing a specifically formulated humic composition and, thereafter, applying the humic composition as an antimicrobial agent for the abatement of Escherichia coli. In at least some applications of the present invention, other substances are introduced in combination with the humic composition thereby synergistically providing in certain applications a greater effect than otherwise independently obtainable.
    Type: Application
    Filed: February 5, 2014
    Publication date: June 5, 2014
    Inventor: Lynn C. Wilford
  • Publication number: 20140147514
    Abstract: A process for extracting vitamins and minerals from a first plant matter(s) is disclosed wherein the said first plant matter(s) is treated with acidic matter followed by extraction with water. Said treatment converts the water-insoluble vitamins and minerals into water-soluble forms leading to a more comprehensive extraction with better yields of the plant constituents. Suitable selection of the first and second plant matter(s) and their proportions yields an extract that is a ready-made formulation of the desired vitamins and minerals in RDA quantities. Other advantages are reduced processing times and processing steps. Extraction of guava fruits, guava leaves, holy basil leaves, lemon peels, amla fruits, annato seeds, Wrightia tinctoria, Lantana camara, bamboo shoots, mustard seeds, and curry leaves is described.
    Type: Application
    Filed: July 30, 2012
    Publication date: May 29, 2014
    Inventors: Ramaswamy Rajendran, Kamala Rajendran
  • Patent number: 8729135
    Abstract: This invention relates to a stabilized aqueous glutaraldehyde solution including 0.005% to 45% m/v, suitably 10% to 45% m/v solution of glutaraldehyde, an alcohol ethoxylate non-ionic surfactant, a buffer and a sufficient amount of a pH modifier to bring the pH of the solution to 6.0 to 8.5. The glutaraldehyde and the alcohol ethoxylate non-ionic surfactant are chemically bound together, suitably by complexing. These stable solutions can be stored for a period of at least six months without the glutaraldehyde polymerizing or the pH dropping below 5.0.
    Type: Grant
    Filed: March 13, 2009
    Date of Patent: May 20, 2014
    Inventor: Antonietta Pamela Martin
  • Patent number: 8728535
    Abstract: In one embodiment of the present invention, a pharmaceutically-acceptable single-dosage formulation consists essentially of about 500 mg of vitamin C; about 400 IUs of vitamin D3; about 125 IUs of vitamin E; about 25 mg of vitamin B1; about 3.4 mg of vitamin B2; about 35 mg of niacin; about 35 mg of vitamin B6; about 1.25 mg of folic acid; about 70 mcg of vitamin B12; about 5 mg of pantothenic acid; about 75 mcg of biotin; about 35 mg of magnesium; about 35 mg of zinc; about 1 mg of copper; about 125 mcg of selenium; about 150 mcg of chromium; about 10 mg of alpha lipoic acid; about 35 mg of co-enzyme Q-10; about 400 mcg of lutein; about 125 mcg of lycopene; and at least one or more excipients.
    Type: Grant
    Filed: June 19, 2012
    Date of Patent: May 20, 2014
    Assignee: Vertical Pharmaceuticals, LLC
    Inventors: Steven A. Squashic, Kevin M. Hudy, David C. Purdy
  • Publication number: 20140134273
    Abstract: The present invention relates to ionic compositions for enhancing wound healing, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride. Methods of enhancing wound healing, enhancing sinonasal mucosal healing, promoting mucosal reciliation, and debriding tissue by administering the compositions of the present invention are also presented.
    Type: Application
    Filed: January 23, 2014
    Publication date: May 15, 2014
    Applicant: Red Oax Holdings, LLC
    Inventor: Kevin Powers
  • Publication number: 20140134272
    Abstract: The present invention relates to ionic compositions for enhancing wound healing, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution. In other embodiments, the ionic components of the composition can include magnesium, bromide, sulfate, sodium, and chloride. Methods of enhancing wound healing, enhancing sinonasal mucosal healing, promoting mucosal reciliation, and debriding tissue by administering the compositions of the present invention are also presented.
    Type: Application
    Filed: January 23, 2014
    Publication date: May 15, 2014
    Applicant: Red Oax Holdings, LLC
    Inventor: Kevin Powers
  • Publication number: 20140127179
    Abstract: A formulation of supplement is able to boost the natural cells, both increasing the population of the natural cells and enhancing the natural cell's activity. The formulation can be administered via different forms, such as tablet, injection, skin absorption and etc. This formulation comprises 16 different components, including Alpha Lipoic Acid, Arabinoxylin, Curcumin, Garlic, Genistein, Ginseng, Lentinan, Mistletoe, N-Acetylcysteine, Resveratrol, Selenium, Vitamin B Complex, Vitamin C, Vitamin D3, Vitamin E and Zinc. By virtue of enhancing the natural killer cells (NKC) in the body, the formation is helpful for the prevention and treatment of a number of different human or animal diseases, such as cancers and viral infections. In addition, certain synergistic effects have been observed between different components in the formulation, which further enhances the beneficial effect of the formulation.
    Type: Application
    Filed: November 4, 2013
    Publication date: May 8, 2014
    Applicant: SCIENTIFIC FORMULATIONS, LLC
    Inventor: Jerry Thomas THORNTHWAITE
  • Publication number: 20140127320
    Abstract: A composition and method adapted for delivery of hydrophilic, biologically-active agents are disclosed. The composition can include a reverse microemulsion formed from at least one hydrophilic, biologically-active agent solubilized by a hydrophobic reverse emulsion surfactant in a non-stinging, volatile, hydrophobic solvent. The non-stinging, volatile, hydrophobic solvent is selected from the group consisting of volatile linear and cyclic siloxanes, volatile linear, branched, and cyclic alkanes, volatile fluorocarbons and chlorofluorocarbons, liquid carbon dioxide under pressure, and combinations thereof. The reverse microemulsion can be an optically clear solution.
    Type: Application
    Filed: October 21, 2013
    Publication date: May 8, 2014
    Applicant: ROCHAL INDUSTRIES, LLP
    Inventors: Joseph Charles Salamone, Xiaoyu Chen, Ann Beal Salamone, Katelyn Elizabeth Reilly
  • Publication number: 20140113004
    Abstract: Methods of inhibiting Barrett's esophagus and/or adenocarcinoma in a subject are provided. In a particular embodiment, the method comprises administering at least one composition comprising at least one zinc compound and at least one pharmaceutically acceptable carrier to the esophagus of the subject. The zinc may be a pharmaceutically acceptable salt of zinc, such as zinc gluconate. The zinc may be administered, for example, orally, topically, or by an implantable medical device. In a particular embodiment, the methods further comprise administering at least one analgesic, anesthetic, or other therapeutic agent or therapy for the treatment of Barrett's esophagus. The method may further comprise monitoring the progression of Barrett's esophagus in the subject.
    Type: Application
    Filed: May 7, 2012
    Publication date: April 24, 2014
    Applicants: Monk Street Partners LLC, Lankenau Institute for Medical Research
    Inventors: James M. Mullin, Jonathan Raines
  • Patent number: 8703174
    Abstract: A pet supplement includes a joint preserving and joint rebuilding composition comprising chicken collagen type II, glucosamine hydrochloride and chondroitin sulfate, a vitamin composition comprising vitamins C, D and K, a mineral composition comprising calcium, magnesium, zinc, copper, manganese and boron, a herbal anti-oxidant cofactor blend comprising citrus bioflavonoids, red grapes anthocyanins, turmeric rhizome, boswellia resin and fennel seed. Each of these ingredients is intimately mixed into the pet supplement and orally delivered to the pet in the form of a segment, paste or powder having a size and weight or other dosage measuring feature adjusted in accordance with the pet's weight. A synergistic action between these ingredients preserves and rebuilds the pet's joints, and is nutritionally beneficial for the pet.
    Type: Grant
    Filed: September 15, 2006
    Date of Patent: April 22, 2014
    Assignee: I did It Inc
    Inventor: Marni Markell Hurwitz
  • Patent number: 8703166
    Abstract: Antimicrobial and algaecidal products are disclosed. In general, the antimicrobial or algaecidal products can be adhered to structural components of buildings and include particles that, when combined with water, produce a solution that is toxic to organisms such as algae. The products provide an algaecidal wash as water percolates on, or through the product, and can prevent or control growth of unsightly algae and other microbes.
    Type: Grant
    Filed: January 20, 2011
    Date of Patent: April 22, 2014
    Inventor: John Flynn
  • Publication number: 20140106002
    Abstract: A homeopathic composition and method for treating a variety of skin irritations, wounds, and diseases is disclosed. The homeopathic composition may contain as active ingredients salicyclic acid, trona or one of its salts, and at least one homeopathic agent.
    Type: Application
    Filed: March 15, 2013
    Publication date: April 17, 2014
    Inventors: Ned L. Jensen, Peter E. Fuller
  • Publication number: 20140105940
    Abstract: The present invention relates to a biocompatible material and in particular to a two-phase or composite biocompatible ceramic material, wherein the first phase is a doped calcium zinc silicate and the second phase is a metal oxide. In an embodiment, the invention has been developed for use in tissue regeneration including bone tissue. In other embodiments, the invention has been developed as a coating to improve the long-term stability of prior art implantable medical devices.
    Type: Application
    Filed: June 1, 2012
    Publication date: April 17, 2014
    Applicant: The University of Sydney
    Inventors: Hala Zreiqat, Seyed-Iman Roohani-Esfahani, Colin Dunstan, Jiao Jiao Li
  • Publication number: 20140099348
    Abstract: Provided is a photocatalytic composition comprising zinc (Zn) doped titanium dioxide (TiO2) nanoparticles, wherein the ratio of titanium dioxide nanoparticles to zinc is from about 5 to about 150. The photocatalytic composition absorbs electromagnetic radiation in a wavelength range from about 200 nm to about 500 nm, and the absorbance of light of wavelengths longer than about 450 nm is less than 50% the absorbance of light of wavelengths shorter than about 350 nm. Further provided is a method for treating or preventing microbial diseases and infestations in a plant and a method for increasing crop yield of a plant by applying the photocatalytic compositions taught herein to the surface of a plant. Also provided is a method for treating microbial diseases on a surface by applying the photocatalytic compositions taught herein to a surface illuminated by artificial light.
    Type: Application
    Filed: November 1, 2013
    Publication date: April 10, 2014
    Inventors: Stewart Benson Averett, Devron R. Averett
  • Publication number: 20140099350
    Abstract: The present invention relates to micro-sized particles having anti-biocontaminant properties. Each particle is comprised of a central metal core, or support structure, (for example, alumina oxide) and has on its surface, one or more anti-biocontaminant metals and at least one redox agent.
    Type: Application
    Filed: March 26, 2013
    Publication date: April 10, 2014
    Inventor: Dynamic Adsorbents, Inc.
  • Patent number: 8691726
    Abstract: A synergistic antimicrobial composition containing a glyphosate compound and zinc pyrithione is provided. Also provided is a method of inhibiting the growth of or controlling the growth of microorganisms in a building material by adding such a synergistic antimicrobial composition. Also provided is a coating composition containing such a synergistic antimicrobial composition, and a dry film made from such a coating composition.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: April 8, 2014
    Assignee: Dow Global Technologies LLC
    Inventors: Emerentiana Sianawati, Sudhakar Balijepalli
  • Patent number: 8691285
    Abstract: Methods of using a non-irritant, low pH acidic composition to destroy undesirable microorganisms are described. The methods may be used on food products, food processing equipment, and in aqueous solutions.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: April 8, 2014
    Assignee: CMS Innovative Technologies, Inc.
    Inventors: Barry Cummins, David Creasey
  • Patent number: 8691725
    Abstract: A synergistic antimicrobial composition containing a glyphosate compound and thiabendazole is provided. Also provided is a method of inhibiting the growth of or controlling the growth of microorganisms in a building material by adding such a synergistic antimicrobial composition. Also provided is a coating composition containing such a synergistic antimicrobial composition, and a dry film made from such a coating composition.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: April 8, 2014
    Assignee: Dow Global Technologies LLC
    Inventors: Emerentiana Sianawati, Sudhakar Balijepalli
  • Patent number: 8686216
    Abstract: The present invention relates to a water-absorbing particulate composition comprising water-absorbing polymer particulate structure comprising partly neutralized, crosslinked polyacrylate, a surface crosslinking agent and a compound of the structure I in which R1, R2, R3 and R4 can be identical or different and in each case represent a hydrogen atom, a halogen atom, a C1- to C4-hydrocarbon group or a hydroxyl group, R5 represents a hydrogen atom, a C1- to C4-hydrocarbon group or an acetyl group, n represents an integer chosen from the group consisting of 1, 2 or 3 and Mn+ represents an n-valent metal cation or an H+ cation. In addition, the present invention also relates to a process for the preparation of a water-absorbing composition, the water-absorbing composition obtainable by this process, a composite, a process for the production of a composite, the composite obtainable by this process, and products, such as hygiene articles.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: April 1, 2014
    Assignee: Evonik Degussa GmbH
    Inventors: Laurent Wattebled, Franck Furno
  • Patent number: 8679468
    Abstract: The present invention provides a deoxidizing multilayered body, which sufficiently suppresses the production of odorous organic components produced with oxidation, and which absorbs oxygen at a fast rate. The present invention is the deoxidizing multilayered body that is constituted by laminating at least an isolation layer (A) that contains a thermoplastic resin, an odor absorption layer (B), which is made from an odor absorbent resin composition (b) that contains an oxidizable thermoplastic resin, a transition metal catalyst, and an odor absorbent, an oxygen absorption layer (C), which is made from an oxygen absorbent resin composition (c) that contains an oxidizable thermoplastic resin and a transition metal catalyst, and an oxygen barrier layer (D), which contains an oxygen barrier substance, in this order.
    Type: Grant
    Filed: August 26, 2009
    Date of Patent: March 25, 2014
    Assignee: Mitsubishi Gas Chemical Company, Inc.
    Inventors: Kimitaka Nakao, Emiko Yokose
  • Publication number: 20140079807
    Abstract: The disclosure is directed to glass compositions that incorporate copper into an otherwise homogeneous glass and to a method for making such glass. This incorporation of the copper into the glass composition imparts significant antimicrobial activity to the glass. A method of making a copper-containing glass article comprises: batching a glass batch comprising: 40-85 SiO2; 10-40 B2O3; 1-19 Al2O3; 0.1-20 CuO or a selected salt of Cu that is convertible into CuO during melting; 0-20 M2O, wherein M is Li, Na, K, or combinations thereof; 0-25 RO, wherein R is Ca, Sr, Mg, or combinations thereof; and 0-20 ZnO. melting the batch to form a melted glass; and forming the melted glass to form the copper-containing glass article having antimicrobial properties.
    Type: Application
    Filed: March 27, 2012
    Publication date: March 20, 2014
    Inventors: Nicholas Francis Borrelli, Odessa Natalie Petzold, Joseph Francis Schroeder, Thomas Philip Seward, Florence Verrier, Ying Wei
  • Publication number: 20140079809
    Abstract: The use of L-carnitine, in combination with antioxidants such as vitamin E and inorganic elements such as manganese, zinc, sodium and potassium, for the preparation of a physiological supplement or medicament for ophthalmic use, for the prevention or treatment of accomodative asthenopia is disclosed.
    Type: Application
    Filed: November 18, 2013
    Publication date: March 20, 2014
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Nicola PESCOSOLIDO, Aleardo KOVERECH
  • Publication number: 20140079810
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Application
    Filed: May 6, 2013
    Publication date: March 20, 2014
    Inventor: Elliott C. Lasser
  • Publication number: 20140079811
    Abstract: Embodiments disclosed herein relate to improved X-ray contrast media compositions and methods of using the same for treating symptoms related to allergic reactions, inflammatory conditions, symptoms of the common cold and certain cancers.
    Type: Application
    Filed: May 7, 2013
    Publication date: March 20, 2014
    Inventor: Elliott C. Lasser
  • Patent number: 8673367
    Abstract: A new composite comprises (a) 10.1-99.9% by weight of elemental Ag and (b) 0.1-89.9% by weight of ZnO, wherein the sum of (a) and (b) makes 90% or more by weight of the composite and wherein the elemental Ag has a primary particle size of 10-200 nm and/or the ZnO has a primary particle size of 0.1 to below 50 ?m and/or the composite has a particle size distribution of 0.1-50 ?m and/or a BET surface area of 10-100 m2/g. The novel composite may be obtained by the steps (i) mixing a first mixture of at least one Ag-salt with a second mixture of at least one Zn-salt thereby forming a third mixture of Ag- and Zn-salts, (ii) adding the third mixture to a mixture of a carbonate source, (iii) co-precipitating of the Ag- and Zn-carbonates formed in step (ii), (iv) washing of the Ag- and Zn-carbonates and (v) thermal decompositing of the Ag- and Zn-carbonates.
    Type: Grant
    Filed: August 16, 2010
    Date of Patent: March 18, 2014
    Assignee: Polymers CRC Ltd.
    Inventors: Thomas Weiβ, Rainer Xalter
  • Publication number: 20140056994
    Abstract: The invention relates to a fixed-dose association of phytate and zinc in synergic proportions for use in the treatment of crystallization of hydroxyapatite. Advantageously, said association is in a molar ratio between the phytate and the zinc exceeding 4:1. The invention also relates to the use of said association for manufacturing a drug for the treatment, prophylaxis and/or prevention crystallization of hydroxyapatite in humans.
    Type: Application
    Filed: February 19, 2013
    Publication date: February 27, 2014
    Applicant: Universitat De Les Illes Balears
    Inventor: Universitat De Les Illes Balears
  • Publication number: 20140056948
    Abstract: A hard tissue regeneration material and a method for manufacturing the same are disclosed. The hard tissue regeneration material of the present invention comprises: ZnO particles selected from the group consisting of crystallized ZnO particles, crystallized ZnO nanorods, nano-ZnO hollow fibers, and a combination thereof; and at least one selected from the group consisting of polycarboxylate cement, glass ionomer cements, and collagen.
    Type: Application
    Filed: February 21, 2013
    Publication date: February 27, 2014
    Applicant: NATIONAL CHENG KUNG UNIVERSITY
    Inventor: National Cheng Kung University
  • Patent number: 8647679
    Abstract: Disclosed herein are core-shell type zinc oxide microparticles, a dispersion containing such microparticles, and a production process and uses of the microparticles and the dispersion. As disclosed herein, the core-shell type zinc oxide microparticles have an average particle diameter of from 50 to 1,000 nm. The core is a secondary particle of spherical shape to the surface of which a polymer is attached as a shell. Methods for making the microparticles include the steps of: mixing together a zinc salt and a polymer in an organic solvent so as to obtain a mixture; and heating/refluxing the mixture at a predetermined temperature so as to cause core-shell type zinc oxide microparticles to precipitate, wherein the zinc salt is zinc acetate; and uses such as cosmetics, resins and fibers which contain the core-shell type zinc oxide microparticles and have an ultraviolet light blocking action.
    Type: Grant
    Filed: February 6, 2009
    Date of Patent: February 11, 2014
    Assignee: National Institute of Advanced Industrial Science and Technology
    Inventors: Noriya Izu, Ichiro Matsubara, Toshio Itoh, Woosuck Shin, Maiko Nishibori